Stay updated with breaking news from Oncoextra Test. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) saw a large drop in short interest in the month of March. As of March 15th, there was short interest totalling 6,520,000 shares, a drop of 7.4% from the February 29th total of 7,040,000 shares. Based on an average trading volume of 1,940,000 shares, the short-interest ratio […]
Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) was the target of a significant drop in short interest in March. As of March 15th, there was short interest totalling 6,520,000 shares, a drop of 7.4% from the February 29th total of 7,040,000 shares. Based on an average trading volume of 1,940,000 shares, the short-interest ratio […]
Values First Advisors Inc. increased its stake in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 21.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 12,973 shares of the medical research company’s stock after purchasing an additional 2,329 shares during the […]
Exact Sciences Co. (NASDAQ:EXAS – Get Free Report)’s stock price rose 7.3% during mid-day trading on Thursday . The stock traded as high as $60.52 and last traded at $60.35. Approximately 1,181,042 shares changed hands during mid-day trading, a decline of 40% from the average daily volume of 1,954,303 shares. The stock had previously closed […]
Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) CEO Kevin T. Conroy sold 6,263 shares of the company’s stock in a transaction on Tuesday, February 27th. The shares were sold at an average price of $56.89, for a total transaction of $356,302.07. Following the completion of the sale, the chief executive officer now directly owns […]